General practices invited to participate in the APCOM Trial

27 June 2022

General practices are invited to participate in the Activating Primary Care COPD Patients with Multimorbidity (APCOM) Trial.

The APCOM Trial, funded by the Australian Government Medical Research Future Fund, is a primary healthcare implementation research study being conducted by Bond University, University of Queensland, UNSW Sydney, Woolcock Institute of Medical Research, University of Wollongong Australia, University of Sydney, Lung Foundation Australia, Australian Primary Health Care Nurses Association, and the RACGP.

The trial aims to improve the quality of life of patients with Chronic Obstructive Pulmonary Disease (COPD) and other chronic health conditions through an innovative practice nurse-led, tailored self-management program in NSW and Queensland general practices.

A recompense of $500 each will be provided to all participating general practices for recruiting eligible patients for the trial. General practices allocated to the intervention arm of the trial will be provided a payment of $60/hour for the practice nurse’s time towards attending a one-day training workshop and delivery of the self-management program to participating patients in five personalised health coaching sessions.

Find more information

If you are interested in participating or have any questions, please contact the Lead Investigator Professor Nick Zwar at [email protected] or 07 5595 5499, or the trial manager Dr Sameera Ansari at [email protected].

Font Resize